Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact

RB nr 37 Zmiana terminu publikacji raportu za pierwsze półrocze 2022 roku

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.